NIKE Inc (NKE) Falls 5.27% for February 08

Equities Staff |

One of the S&P 500’s big losers for Monday February 08 was NIKE Inc (NKE). The company’s stock fell 5.27% to $54.16 on volume of 16.54 million shares.

The stock opened the day at 56.10 and traded between a low of $53.64 and a high of $56.21. The stock finished the day down $3.01 per share. NIKE Inc has an average daily volume of 9.45 million and a total float of 1.7 billion shares. The 50-day SMA for NIKE Inc is $62.72 and its 200-day SMA is $58.24. The high for the stock over the last 52 weeks is $68.20 and the low is $45.35.

Nike Inc designs, develops and markets footwear, apparel, equipment, and accessory products. It is a seller of athletic footwear and athletic apparel. It sells its products through NIKE-owned in-line and factory retail stores and internet websites.

NIKE Inc is centered in Beaverton, OR, and has 62,600 employees. Today’s trading day leaves the company with a market cap of $92.24 billion. The company has a P/S ratio of n/a, P/B ratio of 6.88, and a 40.1.

For a complete fundamental analysis analysis of NIKE Inc, check out’s Stock Valuation Analysis report for NKE. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…